Shire PLC (SHP) Receives "Outperform" Rating from BNP Paribas

Shire PLC (SHP) Receives "Outperform" Rating from BNP Paribas


's stock had its "outperform" rating reiterated by BNP Paribas in a report issued on Monday. They currently have a GBX 5,900 price target on the biopharmaceutical company's stock.



from Biotech News